Wiggill TM - Search Results

1

Changing pattern of lymphoma subgroups at a tertiary academic complex in a high-prevalence HIV setting: a South African perspective.

Wiggill TM, Mantina H, Willem P, Perner Y, Stevens WS. Wiggill TM, et al. J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):460-6. doi: 10.1097/QAI.0b013e31820bb06a. J Acquir Immune Defic Syndr. 2011. PMID: 21239997

2

Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa.

Stevens W, Wiggill T, Horsfield P, Coetzee L, Scott LE. Stevens W, et al. J Virol Methods. 2005 Mar;124(1-2):105-10. doi: 10.1016/j.jviromet.2004.11.009. Epub 2004 Dec 15. J Virol Methods. 2005. PMID: 15664057

3

Characterization of Lymphomas in a high prevalence HIV setting.

Mantina H, Wiggill TM, Carmona S, Perner Y, Stevens WS. Mantina H, et al. Among authors: wiggill tm. J Acquir Immune Defic Syndr. 2010 Apr;53(5):656-60. doi: 10.1097/QAI.0b013e3181bf5544. J Acquir Immune Defic Syndr. 2010. PMID: 20160652

4

Challenges in lymphoma diagnosis in HIV positive patients in the South African setting.

Wiggill TM, Mayne ES, Willem P. Wiggill TM, et al. Transfus Apher Sci. 2013 Oct;49(2):157-62. doi: 10.1016/j.transci.2013.07.020. Epub 2013 Aug 2. Transfus Apher Sci. 2013. PMID: 23981653 Review.

5

Hepatosplenic T-cell lymphoma: A case series.

Ashmore P, Patel M, Vaughan J, Wiggill T, Willem P, van den Berg E, Philip V, Lakha A. Ashmore P, et al. Hematol Oncol Stem Cell Ther. 2015 Jun;8(2):78-84. doi: 10.1016/j.hemonc.2014.09.006. Epub 2014 Oct 13. Hematol Oncol Stem Cell Ther. 2015. PMID: 25450840 Free article.

6

Hematologic malignancies in South Africa 2000-2006: analysis of data reported to the National Cancer Registry.

Schonfeld SJ, Erdmann F, Wiggill T, Singh E, Kellett P, Babb C, Schüz J. Schonfeld SJ, et al. Cancer Med. 2016 Apr;5(4):728-38. doi: 10.1002/cam4.597. Epub 2016 Jan 15. Cancer Med. 2016. PMID: 26773310 Free PMC article.

7

Brief Report: HIV-Associated Hodgkin Lymphoma Involving the Bone Marrow Identifies a Very High-Risk Subpopulation in the Era of Widescale Antiretroviral Therapy Use in Johannesburg, South Africa.

Vaughan J, Perner Y, McAlpine E, Wiggill T. Vaughan J, et al. J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):345-349. doi: 10.1097/QAI.0000000000002276. J Acquir Immune Defic Syndr. 2020. PMID: 32097194

8

Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use.

Vaughan J, Perner Y, Mayne E, Wiggill T. Vaughan J, et al. HIV Med. 2021 Mar;22(3):225-230. doi: 10.1111/hiv.12965. Epub 2020 Oct 6. HIV Med. 2021. PMID: 33022825 Free article.

9

Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory.

Hans L, Steegen K, Ketseoglou I, Mahlumba Z, Cassim N, Wiggill T, Venter WDF, Stevens W. Hans L, et al. Int J Infect Dis. 2021 Sep;110:1-3. doi: 10.1016/j.ijid.2021.06.019. Epub 2021 Jun 15. Int J Infect Dis. 2021. PMID: 34139371 Free PMC article.

10

Changing Patterns of Lymphoma in the Antiretroviral Therapy Era in Johannesburg, South Africa.

Wiggill T, Mayne E, Perner Y, Vaughan J. Wiggill T, et al. J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):252-260. doi: 10.1097/QAI.0000000000002768. J Acquir Immune Defic Syndr. 2021. PMID: 34354010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters